These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1356 related items for PubMed ID: 26224475

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Elevated Serum Gas6 Is a Novel Prognostic Biomarker in Patients with Oral Squamous Cell Carcinoma.
    Jiang T, Liu G, Wang L, Liu H.
    PLoS One; 2015; 10(7):e0133940. PubMed ID: 26207647
    [Abstract] [Full Text] [Related]

  • 4. Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
    Jiang T, Xie P, Liu H.
    J Oral Maxillofac Surg; 2016 Mar; 74(3):650-7. PubMed ID: 26454036
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic and prognostic value of serum miR-99a expression in oral squamous cell carcinoma.
    Chen L, Hu J, Pan L, Yin X, Wang Q, Chen H.
    Cancer Biomark; 2018 Mar; 23(3):333-339. PubMed ID: 30223386
    [Abstract] [Full Text] [Related]

  • 6. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
    Sun L, Jiang R, Li J, Wang B, Ma C, Lv Y, Mu N.
    Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
    [Abstract] [Full Text] [Related]

  • 7. Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma.
    Romani C, Salviato E, Paderno A, Zanotti L, Ravaggi A, Deganello A, Berretti G, Gualtieri T, Marchini S, D'Incalci M, Mattavelli D, Piazza C, Bossi P, Romualdi C, Nicolai P, Bignotti E.
    Theranostics; 2021 Jan; 11(6):2987-2999. PubMed ID: 33456584
    [Abstract] [Full Text] [Related]

  • 8. Serum miR-626 and miR-5100 are Promising Prognosis Predictors for Oral Squamous Cell Carcinoma.
    Shi J, Bao X, Liu Z, Zhang Z, Chen W, Xu Q.
    Theranostics; 2019 Jan; 9(4):920-931. PubMed ID: 30867806
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. MicroRNA-based classifiers for diagnosis of oral cavity squamous cell carcinoma in tissue and plasma.
    Pedersen NJ, Jensen DH, Lelkaitis G, Kiss K, Charabi BW, Ullum H, Specht L, Schmidt AY, Nielsen FC, von Buchwald C.
    Oral Oncol; 2018 Aug; 83():46-52. PubMed ID: 30098778
    [Abstract] [Full Text] [Related]

  • 11. Association of Decreased Expression of Serum miR-9 with Poor Prognosis of Oral Squamous Cell Carcinoma Patients.
    Sun L, Liu L, Fu H, Wang Q, Shi Y.
    Med Sci Monit; 2016 Jan 27; 22():289-94. PubMed ID: 26813876
    [Abstract] [Full Text] [Related]

  • 12. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L, Qi H, Teng J, Su B, Chen H, Wang C, Xia Q.
    Tumour Biol; 2016 Jun 27; 37(6):7777-84. PubMed ID: 26695145
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic and prognostic implications of a serum miRNA panel in oesophageal squamous cell carcinoma.
    Wu C, Wang C, Guan X, Liu Y, Li D, Zhou X, Zhang Y, Chen X, Wang J, Zen K, Zhang CY, Zhang C.
    PLoS One; 2014 Jun 27; 9(3):e92292. PubMed ID: 24651474
    [Abstract] [Full Text] [Related]

  • 14. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
    Manikandan M, Deva Magendhra Rao AK, Arunkumar G, Manickavasagam M, Rajkumar KS, Rajaraman R, Munirajan AK.
    Mol Cancer; 2016 Apr 07; 15():28. PubMed ID: 27056547
    [Abstract] [Full Text] [Related]

  • 15. miR-186, miR-3651 and miR-494: potential biomarkers for oral squamous cell carcinoma extracted from whole blood.
    Ries J, Vairaktaris E, Agaimy A, Kintopp R, Baran C, Neukam FW, Nkenke E.
    Oncol Rep; 2014 Mar 07; 31(3):1429-36. PubMed ID: 24452363
    [Abstract] [Full Text] [Related]

  • 16. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.
    Yan Y, Wang X, Venø MT, Bakholdt V, Sørensen JA, Krogdahl A, Sun Z, Gao S, Kjems J.
    Oncotarget; 2017 Jan 31; 8(5):8206-8214. PubMed ID: 28030794
    [Abstract] [Full Text] [Related]

  • 17. Alterations in miRNA expression patterns in whole blood of OSCC patients.
    Ries J, Vairaktaris E, Kintopp R, Baran C, Neukam FW, Nkenke E.
    In Vivo; 2014 Jan 31; 28(5):851-61. PubMed ID: 25189899
    [Abstract] [Full Text] [Related]

  • 18. MiR-92b as a marker for TPF induced chemotherapy response prediction and prognosis evaluation in with advanced oral squamous cell carcinoma patients.
    Wen J, Xu H, Liu R, Chen Q, Dai Y, Xu Y.
    Cell Mol Biol (Noisy-le-grand); 2020 Jun 05; 66(3):24-31. PubMed ID: 32538743
    [Abstract] [Full Text] [Related]

  • 19. Serum Annexin A2 Level Is Associated With Diagnosis and Prognosis in Patients With Oral Squamous Cell Carcinoma.
    Zhang W, Gao C, Zhang S, Fang G.
    J Oral Maxillofac Surg; 2017 May 05; 75(5):1081-1087. PubMed ID: 27889534
    [Abstract] [Full Text] [Related]

  • 20. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
    Liang YY, Huang JC, Tang RX, Chen WJ, Chen P, Cen WL, Shi K, Gao L, Gao X, Liu AG, Peng XT, Chen G, Huang SN, Fang YY, Gu YY.
    World J Surg Oncol; 2018 Feb 02; 16(1):22. PubMed ID: 29394946
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 68.